Coelonin
Based on 1 Customer Validation
Coelonin is a dihydrophenanthrene with anti-inflammation activity. Coelonin inhibits LPS-induced PTEN phosphorylation. Coelonin inhibits NF-κB activation and p27Kip1 degradation by regulating the PI3K/AKT pathway negatively. Coelonin can inhibit IκBα phosphorylation and degradation and increases the expression of IκBα protein.
For research use only. We do not sell to patients.
- Purity: 98.0%
- CAS No.: 82344-82-9
- Formula: C15H14O3
- Molecular Weight:242.27
-
Storage:
-20°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Biological Activity
|
Akt |
NF-κB |
IL-1β |
IL-6 |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | EC50 |
5.05 μg/mL
Compound: 10
|
Cytotoxicity against human A549 cells after 3 days by sulforhodamine B assay
Cytotoxicity against human A549 cells after 3 days by sulforhodamine B assay
|
[PMID: 19193043] |
| BV-2 | IC50 |
15.2 μM
Compound: 16
|
Antineuroinflammatory activity against mouse BV2 cells assessed as inhibition of LPS-induced NO production incubated for 24 hrs by Griess assay
Antineuroinflammatory activity against mouse BV2 cells assessed as inhibition of LPS-induced NO production incubated for 24 hrs by Griess assay
|
[PMID: 31415170] |
| DU-145 | EC50 |
4.79 μg/mL
Compound: 10
|
Cytotoxicity against human DU145 cells after 3 days by sulforhodamine B assay
Cytotoxicity against human DU145 cells after 3 days by sulforhodamine B assay
|
[PMID: 19193043] |
| HCT-8 | EC50 |
3.84 μg/mL
Compound: 10
|
Cytotoxicity against human HCT8 cells after 3 days by sulforhodamine B assay
Cytotoxicity against human HCT8 cells after 3 days by sulforhodamine B assay
|
[PMID: 19193043] |
| KB | EC50 |
3.4 μg/mL
Compound: 10
|
Cytotoxicity against human KB cells after 3 days by sulforhodamine B assay
Cytotoxicity against human KB cells after 3 days by sulforhodamine B assay
|
[PMID: 19193043] |
| MCF7 | EC50 |
1.8 μg/mL
Compound: 10
|
Cytotoxicity against human MCF7 cells after 3 days by sulforhodamine B assay
Cytotoxicity against human MCF7 cells after 3 days by sulforhodamine B assay
|
[PMID: 19193043] |
| Neutrophil | IC50 |
>10 μM
Compound: 15
|
Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/CB-induced elastase release using MeO-Suc-Ala-Ala-Pro-Val-p-nitroanilide as elastase substrate preincubated for 5 mins followed by fMLP/CB-induction
Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/CB-induced elastase release using MeO-Suc-Ala-Ala-Pro-Val-p-nitroanilide as elastase substrate preincubated for 5 mins followed by fMLP/CB-induction
|
[PMID: 27525452] |
| Neutrophil | IC50 |
0.4 μM
Compound: 15
|
Antiinflammatory activity in human neutrophils assessed as inhibition of FMLP/cytochalasin B-induced superoxide anion generation by measuring superoxide dismutase-inhibitable reduction of ferricytochrome c preincubated for 5 mins followed by FMLP/cytochal
Antiinflammatory activity in human neutrophils assessed as inhibition of FMLP/cytochalasin B-induced superoxide anion generation by measuring superoxide dismutase-inhibitable reduction of ferricytochrome c preincubated for 5 mins followed by FMLP/cytochal
|
[PMID: 27525452] |
| PC-3 | EC50 |
2.82 μg/mL
Compound: 10
|
Cytotoxicity against human PC3 cells after 3 days by sulforhodamine B assay
Cytotoxicity against human PC3 cells after 3 days by sulforhodamine B assay
|
[PMID: 19193043] |
Coelonin (2.5 μg/mL) significantly reduces both NF-κB p65 and p105/50 phosphorylation levels[1].
Coelonin (0-5 μg/mL, 1.5 h) dose dependently reduces the increase of the phosphorylation of PTEN, AKT and IκBa induced by LPS[1].
Coelonin (10 and 20 μg/ml) mitigates particulate matter 2.5 (PM2.5)-induced inflammation by reducing the generation of inflammatory factors, including interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α)[2].
The inhibition of IL-1β, IL-6 and TNF-α expression by Coelonin is independent of PTEN, whereas the inhibition of p27Kip1 degradation results in cell-cycle arrest in the G1 phase, which is dependent on PTEN[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:RAW264.7 cells
-
Concentration:0, 1, 2.5, and 5 μg/mL
-
Incubation Time:1.5 h
-
Result:Dose dependently reduced the increase of p65 accumulation in the nucleus induced by LPS. Dose dependently reversed LPS-induced iNOS and COX2 expression. LPS (200 ng/mL) significantly increased the phosphorylation of PTEN, AKT and inhibitor of NF-κB (IκBa), which was dose-dependently reduced by coelonin pre-treatment.
Chemical Information
-
CAS No. 82344-82-9
-
Appearance Solid
-
Molecular Weight 242.27
-
Formula C15H14O3
-
Color Light yellow to light brown
-
SMILES
OC(C=C1CC2)=CC(OC)=C1C3=C2C=C(O)C=C3
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
-20°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Purity & Documentation
-
Data Sheet (273 KB)
-
SDS (536 KB)
- English - EN (536 KB)
- Français - FR (536 KB)
- Deutsch - DE (536 KB)
- Norwegian - NO (536 KB)
- Español - ES (536 KB)
- Swedish - SV (536 KB)
- Italian - IT (536 KB)
- Portuguese - PT (536 KB)
-
Handling Instructions (2659 KB)
References
[1]. Jiang F, et al. Coelonin, an Anti-Inflammation Active Component of Bletilla striata and Its Potential Mechanism. Int J Mol Sci. 2019 Sep 8;20(18):4422. [Content Brief]
[2]. Cheng W, et al. Inhibition of inflammation-induced injury and cell migration by coelonin and militarine in PM2.5-exposed human lung alveolar epithelial A549 cells. Eur J Pharmacol. 2021 Apr 5;896:173931. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)